Graham Capital Management, L.P. Intellia Therapeutics, Inc. Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 10,818 shares of NTLA stock, worth $180,985. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,818Holding current value
$180,985% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding NTLA
# of Institutions
319Shares Held
88.7MCall Options Held
668KPut Options Held
865K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.3MShares$205 Million2.39% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$161 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.1MShares$152 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.8MShares$80.3 Million3.53% of portfolio
-
State Street Corp Boston, MA4.36MShares$73 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.27B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...